Evidence map›Paper›PMID 24308935›Full record

ArticleJournal of the American Heart Association2013

Unacylated ghrelin promotes skeletal muscle regeneration following hindlimb ischemia via SOD-2-mediated miR-221/222 expression.

Gabriele Togliatto, Antonella Trombetta, Patrizia Dentelli, Paolo Cotogni, Arturo Rosso, Matthias H Tschöp, Riccarda Granata, Ezio Ghigo, Maria F Brizzi

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 85 citations in OpenAlex.

  1. Trial
  2. Article
  3. Autophagy · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Physiological Effect of Ghrelin on Body Systems.International journal of endocrinology · 2020
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Gabriele TogliattoDepartment of Medical Sciences, University of Turin, Turin, Italy.
Antonella Trombetta
Patrizia Dentelli
Paolo Cotogni
Arturo Rosso
Matthias H Tschöp
Riccarda Granata
Ezio Ghigo
Maria F Brizzi
University of Turin · ITHelmholtz Zentrum München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSurgical treatment of peripheral artery disease, even if successful, does not prevent reoccurrence. Under these conditions, increased oxidative stress is a crucial determinant of tissue damage. Given its reported antioxidant effects, we investigated the potential of unacylated-ghrelin (UnAG) to reduce ischemia-induced tissue damage in a mouse model of peripheral artery disease. METHODS AND

resultsWe show that UnAG but not acylated ghrelin (AG) induces skeletal muscle regeneration in response to ischemia via canonical p38/mitogen-actived protein kinase signaling UnAG protected against reactive oxygen species-induced cell injuries by inducing the expression of superoxide dismutase-2 (SOD-2) in satellite cells. This led to a reduced number of infiltrating CD68(+) cells and was followed by induction of the myogenic process and a reduction in functional impairment. Moreover, we found that miR-221/222, previously linked to muscle regeneration processes, was up-regulated and negatively correlated with p57(Kip2) expression in UnAG-treated mice. UnAG, unlike AG, promoted cell-cycle entry in satellite cells of mice lacking the genes for ghrelin and its receptor (GHSR1a). UnAG-induced p38/mitogen-actived protein kinase phosphorylation, leading to activation of the myogenic process, was prevented in SOD-2-depleted SCs. By siRNA technology, we also demonstrated that SOD-2 is the antioxidant enzyme involved in the control of miR-221/222-driven posttranscriptional p57(Kip2) regulation. Loss-of-function experiments targeting miR-221/222 and local pre-miR-221/222 injection in vivo confirmed a role for miR-221/222 in driving skeletal muscle regeneration after ischemia.

conclusionsThese results indicate that UnAG-induced skeletal muscle regeneration after ischemia depends on SOD-2-induced miR-221/222 expression and highlight its clinical potential for the treatment of reactive oxygen species-mediated skeletal muscle damage.

Indexed as

AnimalsAntigens, CDAntigens, Differentiation, MyelomonocyticAntioxidantsCD68 MoleculeCell CycleCell ProliferationCells, CulturedCyclin-Dependent Kinase Inhibitor p57Disease Models, AnimalGhrelinHindlimbIschemiaMaleMiceMice, Inbred BALB CAntigens, CDAntigens, Differentiation, MyelomonocyticAntioxidantsCD68 MoleculeCD68 protein, mouseCdkn1c protein, mouseCyclin-Dependent Kinase Inhibitor p57GhrelinMicroRNAsMIRN221 microRNA, mouseMIRN222 microRNA, mouseMyoD1 myogenic differentiation proteinMyoD Proteinp38 Mitogen-Activated Protein KinasesPax7 protein, mousePAX7 Transcription FactorReactive Oxygen SpeciesReceptors, GhrelinSuperoxide DismutaseSuperoxide Dismutase 2miRNAsROSsatellite cellssuperoxide dismutase‐2UnAG

Identifiers

PMID24308935
PMCPMC3886736
OpenAlexW2106825409

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.